ACCESS TO MEDICINES IN THE ARCTIC DISTRICTS OF THE SAKHA REPUBLIC (YAKUTIA)

Original article

Download article

Sardana M. Tarabukina¹, Anna N. Shishigina²

¹M. K. Ammosov North-Eastern Federal University, Yakutsk, Russia, tcmx@mail.ru, ORCID 0000-0003-4231-2216

²Arctic Research Center of the Sakha Republic (Yakutia), Yakutsk, Russia, schanan@yandex.ru,  ORCID 0000-0003-3597-8669

 

Abstract. Access to medicines is intrinsically linked to fundamental human rights to health and life. The need to make medicines more accessible is articulated in strategic planning documents, including the Strategy for the Development  of the Arctic Zone of the Russian Federation and National Security until 2035. Enacted in 2023, the law “On the Deliveries  of Goods to the Northern Territories” aims to address the situation regarding access to medicines in the Russian Arctic.  This study aims to provide a rationale for a set of government regulation mechanisms aimed at improving access to medicines in the region. Guided by axiological principles, the study employs analysis and synthesis, systems analysis, structural analysis, mathematical tools, and statistical analysis. The study utilizes data from official statistics reports, the National Register  of Medicines, archives run by the Ministry of Health of the Sakha Republic (Yakutia), and local pharmacies. This research contributes to the scientific discourse on social policy issues in Arctic regions, focusing on the unique binary status  of pharmaceutical companies caused by the ambiguous roles played by healthcare and federal authorities. Using Yakutia  as a case study, the article sheds light on the current situation with access to medicines in regions traditionally populated  by indigenous peoples. The analysis of the pharmaceutical market in Yakutia and its Arctic districts from 2009 to 2023 reveals both general positive trends in healthcare and the low effectiveness of existing measures, necessitating a clearer definition of government participation forms. The study gives additional proposals in this domain. Due to the multidimensionality  of interdependent yet separate public (healthcare) and private (pharmacies) sectors, further research can be done into ways to improve the quality of life of the local population in the context of economic and social inequality.

Keywords: Russian Arctic, Sakha Republic (Yakutia), medicines, access, pharmacy, retail sale of medicines

For citation: Tarabukina S. М., Shishigina А. N. Access to medicines in the Arctic districts of the Sakha Republic (Yakutia). Sever i rynok: formirovanie ekonomicheskogo poryadka [The North and the Market: Forming the Economic Order], 2023, no. 4, pp. 190–205. doi:10.37614/2220-802X.4.2023.82.013.

References

  1. Putilo N. V., Volkova N. S., Tsomartova F. V., Kalmykova A. V., Prep’yalov A. V., Makhnik D. I., Barankov V. L., Eremina O. Yu., Mel’nik T. E., Pulyaeva E. V., Shadrin A. D. Pravo grazhdan na lekarstvennoe obespechenie  [The right of citizens to pharmaceutical benefits]. Moscow, Yuridicheskaya Firma Kontrakt, 2017, 216 p. (In Russ.).
  2. Stephen M. P. The Emergence and Scope of the Human Right to Health. Advancing the Human Right to Health, Oxford, 2013, online edn. Oxford Academic, 26 Sept., 2013. DOI: 10.1093/acprof:oso/9780199661619.003.0001.
  3. Awaisu A., Mottram David R. Chapter 6. How Pharmacy Education Contributes to Patient and Pharmaceutical Care. Pharmacy Education in the Twenty First Century and Beyond, Academic Press, 2018, pp. 61–77. DOI: 10.1016/B978-0-12-811909-9.00006-X.
  4. Hepler C. D., Strand L. M., Opportunities and responsibilities in pharmaceutical care. American journal of hospital pharmacy, 1990, 47 (3), pp. 533–543. Available at:https://edisciplinas.usp.br/pluginfile.php/49600/mod_resource/content/1/Hepler_Strand.pdf.
  5. Almarsdóttir A. B., Granas A. G., Blondal A. B. Chapter 3. Clinical and Social Perspectives on Pharmacy Services. Clinical Pharmacy Education, Practice and Research, Elsevier, 2019, pp. 31–40. DOI: 10.1016/B978-0-12-814276-9.00003-9.
  6. Wolff J. The Human Right to Health. New York, W. W. Norton & Company, 2012, 139 p. DOI: 10.2990/33_1_94.
  7. Cipolle R. J., Strand L. M., Morley P. C. Pharmaceutical Care Practice: The Clinician’s Guide, 2nd ed. New York, McGraw-Hill, 2004, 394 p.
  8. Andrioti A. The Right to Health and Pharmaceutical Companies in Developing Countries: Access to Medicines. University of Nottingham. European Master’s Degree in Human Rights and Democratisation A. Y. 2018/2019. Available at: https://repository.gchumanrights.org/server/api/core/bitstreams/6ead5e5e-8cbb-4398-934a-4a6b880bce0c/content.
  9. Gabriel Joseph M. Medical Monopoly: Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry. Chicago, The University of Chicago Press, 2014. 328. Law and History Review, 34 (2), pp. 535–537. DOI:10.1017/S0738248016000122.
  10. Tsomartova F. V. Gosudarstvennye garantii dostupnosti lekarstvennykh sredstv v Rossii i za rubezhom [State guarantees of availability of drugs in Russia and abroad]. Zhurnal zarubezhnogo zakonodatel’stva i sravnitel’nogo pravovedeniya [Journal of Foreign Legislation and Comparative Law], 2018, no. 4, pp. 161–170.  (In Russ.). DOI: 10.12737/art.2018.4.21.
  11. Lo B., Field M. J. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of Interest in Medical Research, Education, and Practice. Washington (DC), National Academies Press (US), 2009. DOI: 10.17226/12598.
  12. Jones E. J., Mackinnon N. J., Tsuyuki R. T. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother, 2005 Sep., 39 (9), pp. 1527–33. DOI: 10.1345/aph.1E456.
  13. Farris K. B., Fernandez-Limos F., Benrimoj S. Ch. Pharmaceutical Care in Community Pharmacies: Practice and Research from Around the World. Annals of Pharmacotherapy, 2005, 39 (9), pp. 1539–1541. DOI: 10.1345/aph.1G049.
  14. Mellish L., Karanges E. A., Litchfield M. J., Schaffer A. L., Blanch B., Daniels B. J., Segrave A., Pearson S.-A. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. BMC Res Notes 8, 634 (2015). DOI: 10.1186/s13104-015-1616-8.
  15. Rovers J. P., Mages M. D. A model for a drug distribution system in remote Australia as a social determinant of health using event structure analysis. BMC Health Serv Res, 17, 677 (2017). DOI: 10.1186/s12913-017-2629-x.
  16. Perehudoff K. Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators. Glob Health Action, 2020, Dec 31, 13 (1). DOI: 10.1080/16549716.2019.1699342.
  17. Krasil’nikova E. A., Baskakov V. A. Farmatsevticheskii rynok Rossii: vyzovy, otsenki, perspektivy [The Russian pharmaceutical market: challenges, assessments, prospects]. Vestnik Altaiskoi akademii ekonomiki i prava [Bulletin of the Altai Academy of Economics and Law], 2019, no. 4, part 2, pp. 222–227. (In Russ.). Available at: https://vaael.ru/ru/article/view?id=432.
  18. Tel’nova E. A. Organizatsiya lekarstvennogo obespecheniya v Rossiiskoi Federatsii [Medicine provisioning in the Russian Federation]. Byulleten’ natsional’nogo nauchno-issledovatel’skogo instituta obshchestvennogo zdorov’ya imeni N. A. Semashko [Bulletin of the N. A. Semashko National Research Institute of Public Health], 2021, no. 1, 100–111. (In Russ.). DOI: 10.25742/NRIPH.2021.01.013.
  19. Tel’nova E. A., Zagoruichenko A. A. O sostoyanii l’gotnogo lekarstvennogo obespecheniya [About the state of preferred medical provision]. Byulleten’ natsional’nogo nauchno-issledovatel’skogo instituta obshchestvennogo zdorov’ya imeni N. A. Semashko [Bulletin of the N. A. Semashko National Research Institute of Public Health], 2021, no. 2, pp. 72–81. (In Russ.). DOI: 10.25742/NRIPH.2021.02.009.
  20. Tel’nova E. A., Zagoruichenko A. A. O gosudarstvennom regulirovanii na rossiiskom farmatsevticheskom rynke i problemakh lekarstvennogo obespecheniya [About state regulation in the Russian pharmaceutical market and problems of drug supply]. Sovremennaya organizatsiya lekarstvennogo obespecheniya [Current Drug Supply Management], 2020, vol. 7, no. 3, pp. 11–20. (In Russ.). DOI: 10.30809/solo.3.2020.2.
  21. Tel’nova E. A., Proklova T. N., Karpova O. B. Nauchnyi analiz faktorov fizicheskoi dostupnosti lekarstvennykh preparatov na primere Sakhalinskoi oblasti (chast’ 1) [A scientific analysis of factors influencing access to medicines: A case study of Sakhalin Oblast (part 1)]. Problemy sotsial’noi gigieny, zdravookhraneniya i istorii meditsiny [Issues in community hygiene, public health and history of medicine], 2017, no. 5, pp. 269–272. (In Russ.). DOI: 10.18821/0869-866H-2017-25-5-269-272.
  22. Tel’nova E. A., Gil’deeva G. N. Assortimentnaya politika kak element dostupnosti i kachestva lekarstvennoi pomoshchi [Assortment policy as an element of availability and quality of medicinal aid]. Remedium [Remedium], 2007, no. 7, pp. 14–20. (In Russ.).
  23. Tel’nova E. A., Krupnova I. V. Lekarstvennoe obespechenie grazhdan, prozhivayushchikh v sel’skoi mestnosti i trudnodostupnykh naselennykh punktakh [Public drug supply in rural areas and hard-to-reach settlements]. Vestnik Roszdravnadzora [Bulletin of Roszdravnadzor], 2012, no. 1, pp. 15–25. (In Russ.).
  24. Tel’nova E. A., Plesovskikh A. V. O lekarstvennom obespechenii naseleniya — ot ostrykh problem k effektivnym resheniyam [Public drug supply: from acute issues to effective solutions]. Vestnik Roszdravnadzora [Bulletin of Roszdravnadzor], 2019, no. 6, pp. 74–81. (In Russ.).
  25. Limonova A. Dostupnost’ lekarstvennoi pomoshchi v vide lekarstvennykh sredstv v Rossiiskoi Federatsii [Availability of pharmaceutical assistance in the form of medicines in the Russian Federation]. Ustoichivoe razvitie nauki i obrazovaniya [Sustainable development of science and education], 2021, no. 5 (56), pp. 54–58. (In Russ.).
  26. Kozlova E. A., Konnova M. A., Ponomareva A. A., Mishenko M. A., Volkov A. A. Perspektivy formirovaniya effektivnoi sistemy lekarstvennoi pomoshchi i povysheniya gosudarstvennykh garantii dostupnosti lekarstvennykh sredstv [Prospects for the development of an effective drug assistance and providing better government guarantees of access to medicines]. Evraziiskoe Nauchnoe Ob”edinenie [Eurasian Scientific Association], 2019, no. 11–3 (57), 200–203. (In Russ.).
  27. Skripko A. A. Marketingovye issledovaniya po otsenke sotsial’noi farmatsevticheskoi pomoshchi naseleniyu Irkutskoi oblasti [Marketing research on the evaluation of social pharmaceutical care provided to the population of the Irkutsk region]. Marketingovye issledovaniya po sovershenstvovaniyu lekarstvennogo obespecheniya naseleniya v regionakh Rossii [Marketing research on improvements in public drug provision in the regions of Russia]. Ufa, Aeterna, 2019, pp. 249–266. (In Russ.).
  28. Fadeeva E. V. Dostupnost’ lekarstvennykh preparatov v usloviyakh medikamentoznogo embargo: po materialam issledovanii [Availability of medicines under conditions of medicinal embargo]. Sotsiologicheskie issledovaniya [Sociological studies], 2019, no. 4, pp. 77–85. (In Russ.). DOI: 10.31857/S013216250004588-9.
  29. Panova L. V. Dostupnost’ meditsinskoi pomoshchi: Rossiya v evropeiskom kontekste [Access to healthcare: Russia in the European context]. Zhurnal issledovanii sotsial’noi politiki [Journal of Social Policy Research], 2019, vol. 17, 2. pp. 177–190. (In Russ.). DOI: 10.17323/727-0634-2019-17-2-177-190.
  30. Mokhov A. A. Farmatsevticheskoe pravo kak fenomen [Pharmaceutical law as a phenomenon]. Aktual’nye problemy rossiiskogo prava [Actual problems of Russian law], 2017, no. 12 (85), pp. 54–62. (In Russ.). DOI: 10.17803/1994-1471.2017.85.12.054-062.
  31. Tsomartova F. V., Putilo N. V. Obshchestvennoe zdorov’e: ot printsipa upravleniya zdravookhraneniem do konstitutsionno-pravovoi tsennosti [Public health: from the principle of healthcare management to the constitutional and legal value]. Zhurnal rossiiskogo prava [Journal of Russian Law], 2023, no. 1, pp. 93–109. (In Russ.).
  32. Znagovan A. S. Osnovnye printsipy farmatsevticheskogo prava [Basic principles of pharmaceutical law]. Meditsinskoe pravo [Medical Law], 2017, no. 3, pp. 51–54. (In Russ.).
  33. Klunko N. S. Otsenka effektivnosti gosudarstvennogo regulirovaniya farmatsevticheskogo kompleksa Rossii [Assessing the effectiveness of government regulation in the Russian pharmaceutical sector]. Gosudarstvennyi sovetnik [State Counselor], 2019, no. 2 (26), pp. 22–27. (In Russ.).
  34. Tarabukina S. M. Metodicheskie podkhody k formirovaniyu regional’noi strategii lekarstvennogo obespecheniya naseleniya na primere Respubliki Sakha (Yakutiya): dis. … kand. farm. nauk: 14.04.03 [Methodological approaches to developing a regional strategy for the provision of medicines to the population: A case study of the Sakha Republic (Yakutia). A PhD (Pharmaceutical Sciences) thesis]. Moscow, 2011, 223 p. (In Russ.).
  35. Tarabukina S. M., Lopatina S. V., Afanas’eva E. B. Metodicheskie podkhody k otsenke dostupnosti narkoticheskikh sredstv i psikhotropnykh veshchestv, primenyaemykh v meditsinskoi praktike v Respublike Sakha (Yakutiya) [Methodological approaches to assessing the availability of narcotic drugs and psychotropic substances used in medical practice in the Sakha Republic (Yakutia)]. Yakutskii meditsinskii zhurnal [Yakutsk Medical Journal], 2018, no. 1 (61), pp. 36–38. (In Russ.). DOI: 10.25789/YMJ.2018.61.11.
  36. Lin A. A., Sokolova S. V., Terekhov M. E. Farmatsevticheskii rynok: kommercheskii roznichnyi sektor [Pharmaceutical market: Commercial retail sector]. Problemy sovremennoi ekonomiki [Problems of modern economics], 2013, no. 3 (47). (In Russ.). Available at: https://cyberleninka.ru/article/n/farmatsevticheskiy-rynok-kommercheskiy-roznichnyy-sektor.
  37. Bushina N. S. Razrabotka metodicheskikh podkhodov k otsenke konkurentosposobnosti aptechnykh organizatsii na regional’nom urovne: avtoref. dis. … kand. farm. nauk: 14.04.03 — organizatsiya farmatsevticheskogo dela [Development of methodological approaches to the assessment of competitiveness of pharmaceutical organizations at the regional level. A PhD (Pharmaceutical Sciences) thesis abstract]. Moscow, 2015, 24 p. (In Russ.). Available at: https://www.dissercat.com/content/razrabotka-metodicheskikh-podkhodov-k-otsenke-konkurentosposobnosti-aptechnykh-organizatsii-/read.
  38. Okoryak Yu. O. Razrabotka metodicheskikh podkhodov k sovershenstvovaniyu deyatel’nosti aptechnykh organizatsii s pozitsii soblyudeniya obyazatel’nykh trebovanii: dis. … kand. farm. nauk: 14.04.03 [Development of methodological approaches to improving the activities of pharmaceutical organizations from the point of view of compliance with mandatory requirements. A PhD (Pharmaceutical Sciences) thesis]. Samara, 2019, 305 p. (In Russ.). Available at: https://www.dissercat.com/content/razrabotka-metodicheskikh-podkhodov-k-sovershenstvovaniyu-deyatelnosti-aptechnykh-organizats.
  39. Sherstneva E. V. Problema dostupnosti lekarstvennoi pomoshchi dlya naseleniya Rossii v nachale XX veka [The problem of accessibility of medicinal care for the Russian population in the early twentieth century]. Remedium [Remedium], 2016, no. 11, pp. 18–20. (In Russ.). DOI: 10.21518/1561-5936-2016-11-18-20.
  40. Valova S. Mery po povysheniyu dostupnosti lekarstvennogo obespecheniya zhitelei sel’skikh poselenii [Measures to improve access to medicines for residents of rural settlements]. Byudzhetnye uchrezhdeniya zdravookhraneniya: bukhgalterskii uchet i nalogooblozhenie [Budgetary healthcare institutions: accounting and taxation], 2010, no. 9. (In Russ.).
  41. Ryzhova O. A., Moroz T. L. Analiz dostupnosti lekarstvennykh sredstv dlya naseleniya otdalennykh territorii Rossii v svete deistvuyushchego zakonodatel’stva [An analysis of access to medicines for the population of remote areas of Russia in the light of current legislation]. Problemy standartizatsii v zdravookhranenii [Problems of standardization in healthcare], 2014, no. 5–6, pp. 37–40. (In Russ.). Available at: https://cyberleninka.ru/article/n/analiz-dostupnosti-lekarstvennyh-sredstv-dlya-naseleniya-otdalennyh-territoriy-rossii-v-svete-deystvuyuschego-zakonodatelstva.
  42. Abrosimova N. V., Kriukova I. V., Sveredyuk M. G. Voprosy pravovogo obespecheniya farmatsevticheskoi deyatel’nosti v obosoblennykh podrazdeleniyakh meditsinskikh organizatsii [Issues in the legal support of pharmaceutical activities in separate subdivisions of medical organizations]. Meditsinskoe parvo [Medical law], 2022, no. 1, pp. 53–56. (In Russ.).
  43. Zyukin D. A., Bystritskaya A. Y., Golovin A. A., Vlasova O. V The share of health care spending in the structure of GDP as a criterion for the healthcare system effectiveness. Revista de la universidad del zulia, 2020, no. 30, 11, pp. 352–363. DOI: 10.46925//rdluz.30.22.
  44. Gruskin S., Raad Z. Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment. PLoS Med, 2010, Sep 28; 7 (9). DOI: 10.1371/journal.pmed.1000310.
  45. Astapenko E. M., Ausheva T. A., Semecheva S. V. Distantsionnaya torgovlya lekarstvennymi preparatami kak odin iz mekhanizmov sovershenstvovaniya dostupnosti lekarstvennoi pomoshchi [Online sales of medicines as one of the mechanisms for improving access to pharmaceutical care]. Vestnik Roszdravnadzora [Bulletin  of Roszdravnadzor], 2023, no. 4. pp. 72–74. (In Russ.).
  46. Petrukhina I. K. Roznichnyi sektor farmatsevticheskogo rynka Privolzhskogo federal’nogo okruga: osnovnye tendentsii i kharakteristiki [The retail sector of the pharmaceutical market in the Volga Federal District: Key trends and characteristics]. Samara, Ofort, 2016, 276 p. (In Russ.).